Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Validation Study: A Prospective, Non-Randomized, Single Arm Trial to Assess the Efficacy of the Comfort Plugâ„¢ in Preventing Urinary Incontinence in Male Subjects with Post Prostatectomy Urinary Incontinence (COMFORT STUDY)
This is a first-in-human, device assessment, feasibility study to assess the safety, effectiveness, comfort and usability of the prototype Comfort Plugâ„¢ for controlling urinary incontinence in male subjects. No drug treatment will be administered.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Device use | Experimental | Only one treatment arm; the "Comfort Plugâ„¢" is a device designed to control urinary incontinence in male subjects by being placed in the urethra to stop urine leakage. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Comfort Plugâ„¢ | Device |
|
| Measure | Description | Time Frame |
|---|---|---|
| To establish safety of the Comfort Plug | Safety is characterized by the absence of complications and adverse events | 30 days |
| International Consultation on Incontinence Questionnaire - Short Form (ICIQ-SF) | The ICIQ is a psychometrically robust patient-completed questionnaire for evaluating the frequency, severity and impact of urinary incontinence (UI) on Quality of Life in men and women. The ICIQ-SF is scored from 0 to 21, with greater scores indicating increased severity of UI. The change from baseline (Visit Day 0) in the ICIQ-SF score at Visit Days 7 and 30 (cohort 1) or Visit Days 14 and 30 (subsequent cohorts) will be examined. | 30 days |
| Weight of protective pads | Change from baseline (Visit Day 0) in the weight of the protective pads a Visit Days 7 and 30 (cohort 1) or Visit Days 14 and 30 (subsequent cohorts). | 30 days |
| Measure | Description | Time Frame |
|---|---|---|
| Incontinence Quality of Life Questionnaire (I-QOL) | The questionnaire has a scale of 22-110; The higher the score, the less incontinence is having a negative impact on the subject's Quality of Life. Change from baseline (Visit Day 0) in the I-QOL instrument scores at Visit Days 14 and 30 for i) avoidance and limiting behavior ii) psychosocial impacts iii) social embarrassment will be examined. | 30 days |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Richard Casey, MD | CMX Research | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Southern Interior Medical Research | Kelowna | British Columbia | V1W4V5 | Canada | ||
| The Fe/Male Health Centres |
Not provided
| Label | URL |
|---|---|
| Abstract from the CUAJ June 2020 (page S59 \& S60) | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D014549 | Urinary Incontinence |
| ID | Term |
|---|---|
| D014555 | Urination Disorders |
| D014570 | Urologic Diseases |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Oakville |
| Ontario |
| L6H3P1 |
| Canada |
| 643094 Ontario Inc. | Scarborough Village | Ontario | M1S4V5 | Canada |
| Dr. Dean Elterman Medicine Professional Corporation | Toronto | Ontario | M5T2S8 | Canada |
| D000091642 | Urogenital Diseases |
| D052801 | Male Urogenital Diseases |
| D059411 | Lower Urinary Tract Symptoms |
| D020924 | Urological Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |